Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total liabilities, at CHF 175.2B, ahead of CVS Health (CHF 150.2B) and AbbVie (CHF 115.6B). Figures as of 19 Nov 2026, 08:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupCHF 175.2B
- Median
- CHF 2.6B
- Combined market value
- CHF 7.67T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IDEXX LaboratoriesIDXX · Health Care | CHF 1.5B | CHF 46.4B | CHF 588.74 | 1.19% up | 1% down | ||
| 102 | InsuletPODD · Health Care | CHF 1.4B | CHF 8.2B | CHF 117.99 | 3.69% down | 58% down | ||
| 103 | Ascendis PharmaASND · Health Care | CHF 1.4B | CHF 14.9B | CHF 227.86 | 0.32% down | 28% up | ||
| 104 | Hims & Hers HealthHIMS · Health Care | CHF 1.4B | CHF 3.4B | CHF 14.37 | 2.85% down | 51% down | ||
| 105 | HaemoneticsHAE · Health Care | CHF 1.3B | CHF 4.7B | CHF 103.56 | 1.60% up | 61% up | ||
| 106 | InsmedINSM · Health Care | CHF 1.3B | CHF 22.2B | CHF 100.98 | 1.69% down | 40% down | ||
| 107 | Medpace HoldingsMEDP · Health Care | CHF 1.3B | CHF 15.3B | CHF 545.25 | 0.95% down | 10% up | ||
| 108 | BioMarin PharmaceuticalBMRN · Health Care | CHF 1.3B | CHF 10B | CHF 51.78 | 4.99% up | 11% up | ||
| 109 | LivaNovaLIVN · Health Care | CHF 1.2B | CHF 4.4B | CHF 79.69 | 2.85% up | 71% up | ||
| 110 | Neurocrine BiosciencesNBIX · Health Care | CHF 1.2B | CHF 13.9B | CHF 137.27 | 1.84% down | 20% up | ||
| 111 | argenxARGX · Health Care | CHF 1.1B | CHF 49.9B | CHF 793.38 | 0.66% down | 4% up | ||
| 112 | HealthEquityHQY · Health Care | CHF 1.1B | CHF 6.8B | CHF 82.02 | 4.45% down | 2% down | ||
| 113 | MSA SafetyMSA · Health Care | CHF 1B | CHF 5.8B | CHF 149.57 | 2.67% up | 11% up | ||
| 114 | Lantheus HoldingsLNTH · Health Care | CHF 958.9M | CHF 5.6B | CHF 85.98 | 0.20% up | 93% up | ||
| 115 | Merit Medical SystemsMMSI · Health Care | CHF 928.6M | CHF 4.3B | CHF 72.43 | 1.70% up | 1% up | ||
| 116 | West Pharmaceutical ServicesWST · Health Care | CHF 922.1M | CHF 23.7B | CHF 340.55 | 2.44% down | 61% up | ||
| 117 | MiniMed GroupMMED · Health Care | CHF 858.9M | CHF 4B | CHF 14.32 | 4.44% down | 4% down | ||
| 118 | ImmunityBioIBRX · Health Care | CHF 844.1M | CHF 6B | CHF 5.65 | 7.03% up | 193% up | ||
| 119 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 743.3M | CHF 5.1B | CHF 36.34 | 0.28% up | 10% up | ||
| 120 | RepligenRGEN · Health Care | CHF 711M | CHF 9.3B | CHF 145.54 | 6.47% up | 5% up | ||
| 121 | United TherapeuticsUTHR · Health Care | CHF 660.7M | CHF 20.7B | CHF 486.64 | 1.16% down | 23% up | ||
| 122 | Legend BiotechLEGN · Health Care | CHF 616.7M | CHF 2.7B | CHF 13.70 | 0.87% up | 42% down | ||
| 123 | Globus MedicalGMED · Health Care | CHF 614.9M | CHF 7.9B | CHF 59.45 | 0.77% up | 16% down | ||
| 124 | Revolution MedicinesRVMD · Health Care | CHF 609.6M | CHF 29.1B | CHF 134.71 | 1.76% down | 131% up | ||
| 125 | NateraNTRA · Health Care | CHF 578.2M | CHF 35.4B | CHF 244.02 | 0.71% up | 32% up | ||
| 126 | ExelixisEXEL · Health Care | CHF 575.8M | CHF 14B | CHF 57.56 | 0.31% down | 63% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | CHF 575.6M | CHF 4.4B | CHF 11.61 | 2.82% down | 129% up | ||
| 128 | AlkermesALKS · Health Care | CHF 562.8M | CHF 6.6B | CHF 39.49 | 3.08% up | 58% up | ||
| 129 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 553.7M | CHF 7.8B | CHF 335.54 | 5.67% down | 24% down | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | CHF 507M | CHF 5.9B | CHF 112.95 | 1.43% down | 7% down | ||
| 131 | ChemedCHE · Health Care | CHF 471M | CHF 6B | CHF 460.83 | 0.01% down | 27% up | ||
| 132 | Caris Life SciencesCAI · Health Care | CHF 462.2M | CHF 4.7B | CHF 16.44 | 2.21% down | 17% down | ||
| 133 | Ligand PharmaceuticalsLGND · Health Care | CHF 458.1M | CHF 5B | CHF 251.78 | 1.67% up | 43% up | ||
| 134 | Mirum PharmaceuticalsMIRM · Health Care | CHF 445.2M | CHF 5.1B | CHF 77.96 | 0.59% up | 31% up | ||
| 135 | Travere TherapeuticsTVTX · Health Care | CHF 413.3M | CHF 4.1B | CHF 42.35 | 1.68% down | 44% up | ||
| 136 | Bio-TechneTECH · Health Care | CHF 403.3M | CHF 9.6B | CHF 61.32 | 0.17% up | 26% up | ||
| 137 | Roivant SciencesROIV · Health Care | CHF 350.9M | CHF 23.7B | CHF 32.65 | 0.05% up | 90% up | ||
| 138 | TG TherapeuticsTGTX · Health Care | CHF 350M | CHF 8.4B | CHF 55.73 | 5.44% up | 107% up | ||
| 139 | PenumbraPEN · Health Care | CHF 336.2M | CHF 10.7B | CHF 270.23 | 0.47% up | 13% up | ||
| 140 | GRAILGRAL · Health Care | CHF 290.1M | CHF 3.9B | CHF 86.06 | 3.57% down | 20% up | ||
| 141 | CRISPR TherapeuticsCRSP · Health Care | CHF 289.5M | CHF 3.3B | CHF 33.88 | 0.10% up | 21% down | ||
| 142 | VaxcytePCVX · Health Care | CHF 267.4M | CHF 7.8B | CHF 49.33 | 1.48% down | 22% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | CHF 253.9M | CHF 4.1B | CHF 23.44 | 0.14% down | 20% down | ||
| 144 | Adaptive BiotechnologiesADPT · Health Care | CHF 242.5M | CHF 3.9B | CHF 23.99 | 0.11% down | 88% up | ||
| 145 | 10x GenomicsTXG · Health Care | CHF 206.5M | CHF 6.3B | CHF 48.10 | 1.37% up | 260% up | ||
| 146 | GlaukosGKOS · Health Care | CHF 200M | CHF 11.6B | CHF 196.46 | 4.18% down | 152% up | ||
| 147 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 177.2M | CHF 7B | CHF 100.34 | 2.08% up | 13% up | ||
| 148 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 165.2M | CHF 6.3B | CHF 80.12 | 0.06% down | 126% up | ||
| 149 | Kodiak SciencesKOD · Health Care | CHF 163.6M | CHF 5.4B | CHF 82.44 | 1.04% up | 396% up | ||
| 150 | Corcept TherapeuticsCORT · Health Care | CHF 159.2M | CHF 6.3B | CHF 57.14 | 3.25% down | 8% down | ||
| 151 | Twist BioscienceTWST · Health Care | CHF 142.4M | CHF 6.7B | CHF 98.07 | 3.88% up | 340% up | ||
| 152 | Kymera TherapeuticsKYMR · Health Care | CHF 137.5M | CHF 8.7B | CHF 102.10 | 0.32% down | 87% up | ||
| 153 | Scholar Rock HoldingSRRK · Health Care | CHF 133.8M | CHF 4.9B | CHF 40.46 | 6.48% up | 14% up | ||
| 154 | BillionToOneBLLN · Health Care | CHF 128.6M | CHF 3.7B | CHF 77.16 | 6.11% down | 0% up | ||
| 155 | ABIVAXABVX · Health Care | CHF 120.8M | CHF 6.2B | CHF 70.66 | 2.11% up | 27% down | ||
| 156 | Krystal BiotechKRYS · Health Care | CHF 96.3M | CHF 7.9B | CHF 265.80 | 5.62% up | 46% up | ||
| 157 | Definium TherapeuticsDFTX · Health Care | CHF 90.8M | CHF 3.4B | CHF 24.55 | 0.88% down | 169% up | ||
| 158 | ImmunovantIMVT · Health Care | CHF 88M | CHF 5.8B | CHF 27.96 | 0.12% down | 43% up | ||
| 159 | Summit TherapeuticsSMMT · Health Care | CHF 77.8M | CHF 7.1B | CHF 8.85 | 1.59% down | 36% down | ||
| 160 | ErascaERAS · Health Care | CHF 59.8M | CHF 4.1B | CHF 11.60 | 0.94% down | 403% up | ||
| 161 | Spyre TherapeuticsSYRE · Health Care | CHF 52.7M | CHF 8.1B | CHF 85.52 | 8.15% up | 286% up | ||
| 162 | Praxis Precision MedicinesPRAX · Health Care | CHF 50.4M | CHF 7.2B | CHF 257.24 | 0.04% up | 61% up | ||
| 163 | HeartflowHTFL · Health Care | CHF 49.6M | CHF 3.4B | CHF 38.68 | 2.51% down | 73% up | ||
| 164 | Protagonist TherapeuticsPTGX · Health Care | CHF 45.1M | CHF 7B | CHF 107.18 | 2.00% up | 46% up | ||
| 165 | CG OncologyCGON · Health Care | CHF 32.9M | CHF 6B | CHF 67.43 | 1.34% up | 85% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | CHF 31.6M | CHF 4B | CHF 70.79 | 3.45% down | 113% up | ||
| 167 | Edgewise TherapeuticsEWTX · Health Care | CHF 25.6M | CHF 3.8B | CHF 34.87 | 1.59% down | 88% up | ||
| 168 | Oruka TherapeuticsORKA · Health Care | CHF 14.1M | CHF 5.5B | CHF 80.70 | 0.60% down | 241% up | ||
| 169 | Belite BioBLTE · Health Care | CHF 8.5M | CHF 5.3B | CHF 131.69 | 0.94% down | 31% up | ||
| 170 | VeradermicsMANE · Health Care | CHF 7.7M | CHF 4.4B | CHF 105.24 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8429 CHF).
Questions and answers
Which health care companies rank first by total liabilities?
UnitedHealth Group (CHF 175.2B), CVS Health (CHF 150.2B) and AbbVie (CHF 115.6B) are the top three of the 170 health care companies ranked by total liabilities as of 19 Nov 2026, 08:24 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of CHF 7.67T as of 19 Nov 2026, 08:24 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.